
AlphaGenome by Google DeepMind
Google DeepMind's AlphaGenome evaluates 1 million base pair DNA sequences to make thousands of predictions, helping scientists identify disease-causing genetic changes.
Loading launches from 4 labs
Topic
Health, medicine and life sciences

Google DeepMind's AlphaGenome evaluates 1 million base pair DNA sequences to make thousands of predictions, helping scientists identify disease-causing genetic changes.

Google DeepMind introduced AlphaGenome Atlas, a dataset predicting outcomes of 9 billion single-letter DNA changes to help researchers prioritize variants using an impact score.
OpenAI updated ChatGPT for Healthcare to include improved clinical answers, providing better responses for medical queries.
OpenAI introduced computer-use agents designed to work across healthcare software to handle real operational and clinical tasks.

Google DeepMind launched AlphaGenome 2, a model that predicts how genetic variants disrupt individual cell types instead of whole tissues.

Google Cloud launched Gemini for healthcare, an AI platform that connects clinical, operational, and administrative systems to handle tasks like medical records synthesis and prior authorization review.
OpenAI released BioBasicsBench, a 100-task benchmark to evaluate how well AI agents interpret raw experimental data and perform everyday wet-lab science tasks.
Google introduced Antigravity and Cheminformatics Skills for agentic cheminformatics. They are designed to speed up drug discovery workflows, search compounds, and propose novel rigidified macrocycles.
OpenAI launched GPT-6 Rosalind, a model tailored for life sciences research that combines biological reasoning with scientific tool use.
Genie 4 is a real-time world model that generates interactive simulations with native audio and physics. It helps build safe training environments for AI agents and robots.